May 2019 Formulary Update
Posted on May 28, 2019
Health New England’s formularies can be accessed on healthnewengland.org using the “Find A Drug” tool at the top of the page.
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and BeHealthy Partnership/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity imitations, step therapy requirements and prior authorization requirements.
Most recently, the following medications have been reviewed:
| Brand Name: Jynarque | Generic Name: Tolvaptan |
| Brand Name: Kapspargo | Generic Name: Metoprolol |
| Brand Name: Lonhala | Generic Name: Glycopyrrolate |
| Brand Name: Pereseris | Generic Name: Risperdone |
| Brand Name: Seebri | Generic Name: Glycopyrrolate |
| Brand Name: Trelegy Ellipta | Generic Name: Fluticasone/Umeclidinium/Vilanterol |
| Brand Name: Utibron | Generic Name: Indacaterol/Glycopyrrolate |
No Comments
Share:
